Clinical Trials Logo

Stroke, Lacunar clinical trials

View clinical trials related to Stroke, Lacunar.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04770363 Completed - Stroke, Acute Clinical Trials

Comparison Between Unihemispheric and Bihemispheric TCDS in Subacute Ischemic Stroke Patients

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

This is a randomized clinical trial to study the effect of tDCS in participants with subacute ischemic stroke, the study participants will be randomly assigned into three groups; bihemispheric, unihemispheric and sham group.

NCT ID: NCT03635177 Completed - Stroke, Lacunar Clinical Trials

Effect of Remote Ischemic Conditioning on Vascular Health in Stroke Patients

VISP
Start date: March 10, 2019
Phase: N/A
Study type: Interventional

The main aim of the current study is to assess cardiovascular effects of remote ischemic conditioning in patients who have suffered from stroke. A group of stroke patients will be subjected to four weeks of daily remote ischemic conditioning and four weeks of placebo and vascular function is assessed as a primary outcome.

NCT ID: NCT03451591 Completed - Clinical trials for Cerebral Small Vessel Diseases

LACunar Intervention (LACI-2) Trial-2

LACI-2
Start date: January 8, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

About 35,000 people each year in the UK have a type of stroke, called 'lacunar' or 'small vessel' stroke, which is different to other common types of stroke and for which there is no proven treatment. It is thought that small vessel stroke is caused by damage to the lining of the tiny blood vessels deep inside the brain that stops them functioning normally. This not only causes stroke but, perhaps more importantly, causes problems with thinking and walking, possibly causing up to 45% of all dementias either on its own, or mixed with Alzheimer's disease (about 350,000 patients in the UK). Some drugs that are commonly used in other blood vessel diseases may help improve small vessel function and prevent worsening of brain damage. One drug (cilostazol) has been tested in patients with stroke in the Asia Pacific countries but not on dementia; the other drug (isosorbide mononitrate) is widely used in the UK for heart disease but not stroke. The investigators want to set up a clinical trial to test if the study methods are practical so that patients and trial centres can follow the procedures, and to confirm how many patients have more stroke-like symptoms or experience worsening of their thinking skills. This information is needed to be sure that a very large clinical trial to find out if these drugs can prevent worsening of small vessel disease will be possible.

NCT ID: NCT02801032 Completed - Clinical trials for Cerebral Small Vessel Diseases

Effect of Tadalafil on Cerebral Large Arteries in Stroke

ETLAS
Start date: November 29, 2016
Phase: Phase 2
Study type: Interventional

In a double blind placebo-controlled cross-over study the effect of tadalafil on blood flow velocity in the large arteries of the brain, cortical brain oxygenation, peripheral endothelial function, and endothelial biomarkers will be tested in patients with lacunar stroke caused by cerebral small vessel disease.